HOME分野紹介 > がん予防研究分野

がん予防研究分野

研究業績

  1. Abe M, Ito H, Oze I, Nomura M, Ogawa Y, Matsuo K. The more from East-Asian, the better: risk prediction of colorectal cancer risk by GWAS-identified SNPs among Japanese. Journal of cancer research and clinical oncology. 2017;143(12):2481-2492.
  2. Adachi Y, Sawaki M, Hattori M, et al. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma. Breast cancer (Tokyo, Japan). 2018.
  3. Akter S, Kashino I, Mizoue T, et al. Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Japanese journal of clinical oncology. 2016;46(8):781-787.
  4. Amankwah EK, Lin HY, Tyrer JP, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic epidemiology. 2015;39(8):689-697.
  5. Aoki K, Nakamura H, Suzuki H, et al. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro-oncology. 2018;20(1):66-77.
  6. Asano T, Natsume S, Senda Y, et al. Incidence and risk factors for anastomotic stenosis of continuous hepaticojejunostomy after pancreaticoduodenectomy. Journal of hepato-biliary-pancreatic sciences. 2016;23(10):628-635.
  7. Babic A, Cramer DW, Kelemen LE, et al. Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium. Cancer causes & control : CCC. 2017;28(5):459-468.
  8. Brenner DR, Amos CI, Brhane Y, et al. Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis. 2015;36(11):1314-1326.
  9. Brouckaert O, Rudolph A, Laenen A, et al. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast cancer research : BCR. 2017;19(1):119.
  10. Camargo MC, Kim KM, Matsuo K, et al. Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer. Helicobacter. 2016;21(2):153-157.
  11. Campa D, Pastore M, Capurso G, et al. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. International journal of cancer. 2018;142(2):290-296.
  12. Campa D, Pastore M, Gentiluomo M, et al. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget. 2016;7(35):57011-57020.
  13. Cannioto R, LaMonte MJ, Risch HA, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(7):1114-1124.
  14. Cannioto RA, LaMonte MJ, Kelemen LE, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British journal of cancer. 2016;115(1):95-101.
  15. Chen Y, Wu F, Saito E, et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia. 2017;60(6):1022-1032.
  16. Chihara D, Ito H, Izutsu K, et al. Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006. International journal of cancer. 2015;137(5):1217-1223.
  17. Chihara D, Ito H, Matsuo K. [Comparison of the incidence and trends of hematologic malignancies between Japan and the United States]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2015;56(4):366-374.
  18. Chornokur G, Lin HY, Tyrer JP, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PloS one. 2015;10(6):e0128106.
  19. Darabi H, Beesley J, Droit A, et al. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Scientific reports. 2016;6:32512.
  20. Darabi H, McCue K, Beesley J, et al. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. American journal of human genetics. 2015;97(1):22-34.
  21. Delahaye-Sourdeix M, Anantharaman D, Timofeeva MN, et al. A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. Journal of the National Cancer Institute. 2015;107(5).
  22. Dunning AM, Michailidou K, Kuchenbaecker KB, et al. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature genetics. 2016;48(4):374-386.
  23. Easton DF, Lesueur F, Decker B, et al. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of medical genetics. 2016;53(5):298-309.
  24. Edefonti V, Hashibe M, Parpinel M, et al. Natural vitamin C intake and the risk of head and neck cancer: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. International journal of cancer. 2015;137(2):448-462.
  25. Fehringer G, Brenner DR, Zhang ZF, et al. Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. International journal of cancer. 2017;140(9):1976-1984.
  26. Fernandez E, Lugo A, Clancy L, Matsuo K, La Vecchia C, Gallus S. Smoking dependence in 18 European countries: Hard to maintain the hardening hypothesis. Preventive medicine. 2015;81:314-319.
  27. Ferro A, Morais S, Rota M, et al. Tobacco smoking and gastric cancer: meta-analyses of published data versus pooled analyses of individual participant data (StoP Project). European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2018;27(3):197-204.
  28. Fowke JH, McLerran DF, Gupta PC, et al. Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. American journal of epidemiology. 2015;182(5):381-389.
  29. French JD, Johnatty SE, Lu Y, et al. Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget. 2016;7(6):6353-6368.
  30. Fujisawa S, Mizuta S, Akiyama H, et al. Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. American journal of hematology. 2017;92(4):367-374.
  31. Fukumoto K, Ito H, Matsuo K, et al. Cigarette smoke inhalation and risk of lung cancer: a case-control study in a large Japanese population. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2015;24(3):195-200.
  32. Ghoussaini M, Edwards SL, Michailidou K, et al. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature communications. 2018;9:16193.
  33. Ghoussaini M, French JD, Michailidou K, et al. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. American journal of human genetics. 2016;99(4):903-911.
  34. Guo X, Long J, Zeng C, et al. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015;24(11):1680-1691.
  35. Hamamoto R, Ito H, Hirohara M, Chang R, Hongo-Hirasaki T, Hayashi T. Interactions between protein molecules and the virus removal membrane surface: Effects of immunoglobulin G adsorption and conformational changes on filter performance. Biotechnology progress. 2018;34(2):379-386.
  36. Hampras SS, Sucheston-Campbell LE, Cannioto R, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 2016;7(43):69097-69110.
  37. Han MR, Long J, Choi JY, et al. Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci. Human molecular genetics. 2016;25(15):3361-3371.
  38. Han MR, Zheng W, Cai Q, et al. Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis. 2017;38(5):511-518.
  39. Hidaka A, Sasazuki S, Matsuo K, et al. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study. International journal of cancer. 2016;139(4):759-768.
  40. Hijioka S, Hosoda W, Matsuo K, et al. Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(16):4625-4632.
  41. Hiwa R, Ikari K, Ohmura K, et al. HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies. The Journal of rheumatology. 2018;45(4):470-480.
  42. Hori H, Kudoh T, Nishimura S, et al. Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. International journal of clinical oncology. 2017;22(2):387-396.
  43. Horibe K, Yumura-Yagi K, Kudoh T, et al. Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial. Journal of pediatric hematology/oncology. 2017;39(2):81-89.
  44. Horne HN, Chung CC, Zhang H, et al. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. PloS one. 2016;11(8):e0160316.
  45. Hosono S, Ito H, Oze I, et al. Polymorphisms in CYP19A1, HSD17B1 and HSD17B2 genes and serum sex hormone level among postmenopausal Japanese women. Maturitas. 2015;82(4):394-401.
  46. Hosono S, Ito H, Oze I, et al. A risk prediction model for colorectal cancer using genome-wide association study-identified polymorphisms and established risk factors among Japanese: results from two independent case-control studies. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2016;25(6):500-507.
  47. Huang R, Wei Y, Hung RJ, et al. Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine. 2015;2(11):1677-1685.
  48. Huang R, Wei Y, Hung RJ, et al. Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine. 2015;2(11):1677-1685.
  49. Idota A, Sawaki M, Yoshimura A, et al. Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer. SpringerPlus. 2016;5(1):1095.
  50. Inoue S, Hosono S, Ito H, et al. Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993-2000 to 2001-2006 in Japan. Journal of epidemiology. 2018;28(2):75-80.
  51. Ishioka K, Masaoka H, Ito H, et al. Association between ALDH2 and ADH1B polymorphisms, alcohol drinking and gastric cancer: a replication and mediation analysis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2018.
  52. Iso H, Matsuo K, Katanoda K, Fujiwara T. New Policy of the Journal of Epidemiology Regarding the Relationship With the Tobacco Industry. Journal of epidemiology. 2018;28(1):1-2.
  53. Ito H, Matsuo K. Molecular epidemiology, and possible real-world applications in breast cancer. Breast cancer (Tokyo, Japan). 2016;23(1):33-38.
  54. Jim HS, Lin HY, Tyrer JP, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of genetics and genome research. 2015;2(2).
  55. Kakiuchi T, Takahara T, Kasugai Y, et al. Modeling mesothelioma utilizing human mesothelial cells reveals involvement of phospholipase-C beta 4 in YAP-active mesothelioma cell proliferation. Carcinogenesis. 2016.
  56. Kar SP, Beesley J, Amin Al Olama A, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer discovery. 2016;6(9):1052-1067.
  57. Kar SP, Tyrer JP, Li Q, et al. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015;24(10):1574-1584.
  58. Kashino I, Akter S, Mizoue T, et al. Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in Japan. International journal of cancer. 2018.
  59. Kashino I, Mizoue T, Tanaka K, et al. Vegetable consumption and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Japanese journal of clinical oncology. 2015;45(10):973-979.
  60. Kasugai Y, Yoshida N, Ohshima K, Matsuo K, Seto M, Tsuzuki S. New mouse model of acute adult T-cell leukemia generated by transplantation of AKT, BCLxL, and HBZ-transduced T cells. Cancer science. 2016;107(8):1072-1078.
  61. Kawaguchi T, Shima T, Mizuno M, et al. Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. PloS one. 2018;13(1):e0185490.
  62. Kawakita D, Lee YA, Turati F, et al. Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium. International journal of cancer. 2017;141(9):1811-1821.
  63. Kawakita D, Matsuo K. Alcohol and head and neck cancer. Cancer metastasis reviews. 2017;36(3):425-434.
  64. Kawakita D, Oze I, Hosono S, et al. Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma. Journal of epidemiology. 2016;26(6):292-299.
  65. Koyama T, Kuriyama N, Ozaki E, et al. Genetic Variants of RAMP2 and CLR are Associated with Stroke. Journal of atherosclerosis and thrombosis. 2017;24(12):1267-1281.
  66. Koyama T, Matsui D, Kuriyama N, et al. Genetic variants of SLC17A1 are associated with cholesterol homeostasis and hyperhomocysteinaemia in Japanese men. Scientific reports. 2015;5:15888.
  67. Koyanagi YN, Ito H, Oze I, et al. Development of a prediction model and estimation of cumulative risk for upper aerodigestive tract cancer on the basis of the aldehyde dehydrogenase 2 genotype and alcohol consumption in a Japanese population. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2017;26(1):38-47.
  68. Koyanagi YN, Matsuo K, Ito H, et al. Body-Mass Index and Pancreatic Cancer Incidence: A Pooled Analysis of Nine Population-Based Cohort Studies With More Than 340,000 Japanese Subjects. Journal of epidemiology. 2017.
  69. Koyanagi YN, Matsuo K, Ito H, et al. Cigarette smoking and the risk of head and neck cancer in the Japanese population: a systematic review and meta-analysis. Japanese journal of clinical oncology. 2016;46(6):580-595.
  70. Kudo K, Hotta K, Ichihara E, et al. Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703. Cancer chemotherapy and pharmacology. 2015;76(2):251-256.
  71. Kuwahara K, Yamamoto-Ibusuki M, Zhang Z, et al. GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development. Cancer science. 2016;107(4):469-477.
  72. Lawrenson K, Iversen ES, Tyrer J, et al. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis. 2015;36(11):1341-1353.
  73. Lawrenson K, Kar S, McCue K, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature communications. 2016;7:12675.
  74. Lawrenson K, Li Q, Kar S, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature communications. 2015;6:8234.
  75. Leoncini E, Edefonti V, Hashibe M, et al. Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. European journal of epidemiology. 2016;31(4):369-383.
  76. Liu J, Loncar I, Collee JM, et al. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific reports. 2016;6:36874.
  77. Lu Y, Sobue T, Kitamura T, et al. Cigarette smoking, alcohol drinking, and oral cavity and pharyngeal cancer in the Japanese: a population-based cohort study in Japan. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2018;27(2):171-179.
  78. Machiela MJ, Hsiung CA, Shu XO, et al. Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. International journal of cancer. 2015;137(2):311-319.
  79. Machiela MJ, Zhou W, Karlins E, et al. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nature communications. 2016;7:11843.
  80. Maeda A, Ura T, Asano C, et al. A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin. Asia-Pacific journal of clinical oncology. 2016;12(3):254-258.
  81. Maeda Y, Nishimori H, Yoshida I, et al. Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707. Haematologica. 2017;102(12):2097-2103.
  82. Makimoto G, Kubo T, Oze I, et al. Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery. Japanese journal of clinical oncology. 2018;48(3):287-290.
  83. Masaoka H, Gallus S, Ito H, et al. Aldehyde Dehydrogenase 2 Polymorphism Is a Predictor of Smoking Cessation. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2017;19(9):1087-1094.
  84. Masaoka H, Ito H, Gallus S, et al. Combination of ALDH2 and ADH1B polymorphisms is associated with smoking initiation: A large-scale cross-sectional study in a Japanese population. Drug and alcohol dependence. 2017;173:85-91.
  85. Masaoka H, Ito H, Soga N, et al. Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: gene-environment interaction. Carcinogenesis. 2016;37(6):583-588.
  86. Masaoka H, Ito H, Yokomizo A, Eto M, Matsuo K. Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan. Cancer science. 2017;108(8):1673-1680.
  87. Masaoka H, Matsuo K, Ito H, et al. Cigarette smoking and bladder cancer risk: an evaluation based on a systematic review of epidemiologic evidence in the Japanese population. Japanese journal of clinical oncology. 2016;46(3):273-283.
  88. Masaoka H, Matsuo K, Sawada N, et al. Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study. International journal of cancer. 2017;141(12):2480-2488.
  89. Matsuo K. Message from the new Editor-in-Chief. Journal of epidemiology. 2017;27(1):1.
  90. Meeks HD, Song H, Michailidou K, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 2016;108(2).
  91. Michailidou K, Beesley J, Lindstrom S, et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature genetics. 2015;47(4):373-380.
  92. Michailidou K, Lindstrom S, Dennis J, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551(7678):92-94.
  93. Milne RL, Kuchenbaecker KB, Michailidou K, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature genetics. 2017;49(12):1767-1778.
  94. Minlikeeva AN, Freudenheim JL, Cannioto RA, et al. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. British journal of cancer. 2017;117(7):1063-1069.
  95. Minlikeeva AN, Freudenheim JL, Cannioto RA, et al. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer causes & control : CCC. 2017;28(5):469-486.
  96. Minlikeeva AN, Freudenheim JL, Eng KH, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017;26(9):1470-1473.
  97. Miura K, Hirakawa H, Uemura H, et al. Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial. Auris, nasus, larynx. 2017;44(3):319-326.
  98. Morishima S, Kashiwase K, Matsuo K, et al. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. Haematologica. 2016;101(4):491-498.
  99. Nagamatsu Y, Oze I, Aoe K, et al. Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study. BMC cancer. 2018;18(1):350.
  100. Nakagawa H, Ito H, Hosono S, et al. Changes in trends in colorectal cancer incidence rate by anatomic site between 1978 and 2004 in Japan. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2017;26(4):269-276.
  101. Nakagawa-Senda H, Hachiya T, Shimizu A, et al. A genome-wide association study in the Japanese population identifies the 12q24 locus for habitual coffee consumption: The J-MICC Study. Scientific reports. 2018;8(1):1493.
  102. Nakagawa-Senda H, Ito H, Hosono S, Oze I, Tanaka H, Matsuo K. Coffee consumption and the risk of colorectal cancer by anatomical subsite in Japan: Results from the HERPACC studies. International journal of cancer. 2017;141(2):298-308.
  103. Nakagawa-Senda H, Yamaguchi M, Matsuda T, et al. Cancer Prevalence in Aichi, Japan for 2012: Estimates Based on Incidence and Survival Data from Population-Based Cancer Registry. Asian Pacific journal of cancer prevention : APJCP. 2017;18(8):2151-2156.
  104. Nakane H, Hirano M, Ito H, et al. Impact of metallothionein gene polymorphisms on the risk of lung cancer in a Japanese population. Molecular carcinogenesis. 2015;54 Suppl 1:E122-128.
  105. Nakao H, Wakai K, Ishii N, et al. Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects. BMC gastroenterology. 2016;16(1):83.
  106. Narita Y, Kadowaki S, Oze I, et al. Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients. Journal of gastrointestinal oncology. 2018;9(1):52-63.
  107. Niibe Y, Onda T, Matsuo K, Inoue Y, Hayakawa K. Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results. Anticancer research. 2017;37(12):6983-6988.
  108. Ninomiya K, Ichihara E, Hotta K, et al. Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol. Clinical lung cancer. 2017;18(2):245-249.
  109. Nishida Y, Hara M, Sakamoto T, et al. Influence of cigarette smoking and inflammatory gene polymorphisms on glycated hemoglobin in the Japanese general population. Preventive medicine reports. 2016;3:288-295.
  110. Nomoto H, Takami A, Espinoza JL, et al. Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. International journal of hematology. 2015;102(4):507-508.
  111. Nomoto H, Takami A, Espinoza JL, et al. A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. International journal of hematology. 2015;102(4):460-470.
  112. Nomura M, Oze I, Abe T, et al. Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis. Cancer chemotherapy and pharmacology. 2015;76(2):357-363.
  113. Nomura M, Oze I, Kodaira T, et al. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. International journal of clinical oncology. 2016;21(5):890-898.
  114. Okumura N, Sonobe M, Okabe K, et al. Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001. International journal of clinical oncology. 2017;22(2):274-282.
  115. Orr N, Dudbridge F, Dryden N, et al. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. Human molecular genetics. 2015;24(10):2966-2984.
  116. Otsu H, Iimori M, Ando K, et al. Gastric Cancer Patients with High PLK1 Expression and DNA Aneuploidy Correlate with Poor Prognosis. Oncology. 2016;91(1):31-40.
  117. Oze I, Shimada S, Nagasaki H, et al. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer. Journal of cancer research and clinical oncology. 2017;143(3):551-554.
  118. Permuth JB, Pirie A, Ann Chen Y, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human molecular genetics. 2016;25(16):3600-3612.
  119. Praestegaard C, Jensen A, Jensen SM, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. International journal of cancer. 2017;140(11):2422-2435.
  120. Praud D, Rota M, Pelucchi C, et al. Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2018;27(2):124-133.
  121. Rota M, Pelucchi C, Bertuccio P, et al. Alcohol consumption and gastric cancer risk-A pooled analysis within the StoP project consortium. International journal of cancer. 2017;141(10):1950-1962.
  122. Sado J, Kitamura T, Kitamura Y, et al. Association between coffee consumption and all-sites cancer incidence and mortality. Cancer science. 2017;108(10):2079-2087.
  123. Sado J, Kitamura T, Kitamura Y, et al. Rationale, design, and profile of the Three-Prefecture Cohort in Japan: A 15-year follow-up. Journal of epidemiology. 2017;27(4):193-199.
  124. Saito E, Inoue M, Tsugane S, et al. Smoking cessation and subsequent risk of cancer: A pooled analysis of eight population-based cohort studies in Japan. Cancer epidemiology. 2017;51:98-108.
  125. Sampson JN, Wheeler WA, Yeager M, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 2015;107(12):djv279.
  126. Sasakabe T, Wakai K, Kawai S, et al. Modification of the Associations of Alcohol Intake With Serum Low-Density Lipoprotein Cholesterol and Triglycerides by ALDH2 and ADH1B Polymorphisms in Japanese Men. Journal of epidemiology. 2018;28(4):185-193.
  127. Sasaki M, Harada S, Kawasaki Y, et al. Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population. Scientific reports. 2018;8(1):785.
  128. Sawabe M, Ito H, Oze I, et al. Heterogeneous impact of alcohol consumption according to treatment method on survival in head and neck cancer: A prospective study. Cancer science. 2017;108(1):91-100.
  129. Sawabe M, Ito H, Takahara T, et al. Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study. Cancer. 2018;124(1):118-124.
  130. Schumacher FR, Schmit SL, Jiao S, et al. Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nature communications. 2015;6:8739.
  131. Schumacher FR, Schmit SL, Jiao S, et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nature communications. 2015;6:7138.
  132. Seow WJ, Matsuo K, Hsiung CA, et al. Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. Human molecular genetics. 2017;26(2):454-465.
  133. Shi J, Park JH, Duan J, et al. Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data. PLoS genetics. 2016;12(12):e1006493.
  134. Shi J, Zhang Y, Zheng W, et al. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International journal of cancer. 2016;139(6):1303-1317.
  135. Shiga Y, Akiyama M, Nishiguchi KM, et al. Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma. Human molecular genetics. 2018;27(8):1486-1496.
  136. Shimanoe C, Hachiya T, Hara M, et al. A genome-wide association study of coping behaviors suggests FBXO45 is associated with emotional expression. Genes, brain, and behavior. 2018:e12481.
  137. Shimelis H, Mesman RLS, Von Nicolai C, et al. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer research. 2017;77(11):2789-2799.
  138. Shiraishi K, Okada Y, Takahashi A, et al. Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma. Nature communications. 2016;7:12451.
  139. Soh J, Okumura N, Nakata M, et al. Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701. Japanese journal of clinical oncology. 2016;46(8):741-747.
  140. Soh J, Toyooka S, Matsuo K, et al. Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma. Oncology letters. 2015;10(3):1775-1782.
  141. Soh SX, Siddiqui FJ, Allen JC, et al. A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer. Oncotarget. 2017;8(25):41474-41486.
  142. Sugita J, Kawashima N, Fujisaki T, et al. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015;21(9):1646-1652.
  143. Takachi R, Inoue M, Sugawara Y, et al. Fruit and vegetable intake and the risk of overall cancer in Japanese: A pooled analysis of population-based cohort studies. Journal of epidemiology. 2017;27(4):152-162.
  144. Takahara T, Matsuo K, Seto M, Nakamura S, Tsuzuki S. Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model. Cancer science. 2016;107(11):1572-1580.
  145. Takenaka K, Shimoda K, Uchida N, et al. Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. International journal of hematology. 2017;105(1):59-69.
  146. Taniguchi A, Miyahara N, Oda N, et al. Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease. Acta medica Okayama. 2017;71(5):453-457.
  147. Taniguchi C, Sakakibara H, Saka H, Oze I, Tanaka H. Japanese Nurses' Perceptions Toward Tobacco Use Intervention for Hospitalized Cancer Patients Who Entered End of Life. Cancer nursing. 2016;39(6):E45-e51.
  148. Taniguchi C, Tanaka H, Saka H, et al. Cognitive, behavioural and psychosocial factors associated with successful and maintained quit smoking status among patients who received smoking cessation intervention with nurses' counselling. Journal of advanced nursing. 2017;73(7):1681-1695.
  149. Taniguchi C, Tanaka H, Saka H, et al. Changes in self-efficacy associated with success in quitting smoking in participants in Japanese smoking cessation therapy. International journal of nursing practice. 2018.
  150. Terao C, Okada Y, Ikari K, et al. Genetic landscape of interactive effects of HLA-DRB1 alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese population. Journal of medical genetics. 2017;54(12):853-858.
  151. Tomita N, Oze I, Shimizu H, et al. International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer. Nagoya journal of medical science. 2015;77(4):637-646.
  152. Toyooka S, Okumura N, Nakamura H, et al. A multi-center randomized controlled study of paclitaxel plus carboplatin versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018.
  153. Toyoshima O, Tanikawa C, Yamamoto R, et al. Decrease in PSCA expression caused by Helicobacter pylori infection may promote progression to severe gastritis. Oncotarget. 2018;9(3):3936-3945.
  154. Uchino K, Mizuno S, Mizutani M, et al. Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies. Transplant immunology. 2016;38:60-66.
  155. Uemura H, Katsuura-Kamano S, Yamaguchi M, et al. Variant of the clock circadian regulator (CLOCK) gene and related haplotypes are associated with the prevalence of type 2 diabetes in the Japanese population. Journal of diabetes. 2016;8(5):667-676.
  156. Ueno M, Ohkawa S, Morimoto M, et al. Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese. Scientific reports. 2015;5:17018.
  157. Ugai T, Kanda Y, Morishima Y, Matsuo K. Role of Genetic Polymorphism of ALDH2 in Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017;23(8):1374-1380.
  158. Ugai T, Kelemen LE, Mizuno M, et al. Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium. Cancer science. 2018;109(2):435-445.
  159. Ugai T, Matsuo K, Oze I, et al. Smoking and subsequent risk of acute myeloid leukaemia: A pooled analysis of 9 cohort studies in Japan. Hematological oncology. 2018;36(1):262-268.
  160. Ugai T, Matsuo K, Sawada N, et al. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan. International journal of cancer. 2018;142(6):1130-1138.
  161. Ugai T, Matsuo K, Sawada N, et al. Coffee and Green Tea Consumption and Subsequent Risk of Malignant Lymphoma and Multiple Myeloma in Japan: The Japan Public Health Center-based Prospective Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017;26(8):1352-1356.
  162. Ugai T, Matsuo K, Sawada N, et al. Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre-based Prospective Study. British journal of haematology. 2017;178(5):747-755.
  163. Ugai T, Matsuo K, Sawada N, et al. Smoking and subsequent risk of leukemia in Japan: The Japan Public Health Center-based Prospective Study. Journal of epidemiology. 2017;27(7):305-310.
  164. Urayama KY, Takagi M, Kawaguchi T, et al. Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese. Scientific reports. 2018;8(1):789.
  165. Wakai K, Sugawara Y, Tsuji I, et al. Risk of lung cancer and consumption of vegetables and fruit in Japanese: A pooled analysis of cohort studies in Japan. Cancer science. 2015;106(8):1057-1065.
  166. Wang Z, Seow WJ, Shiraishi K, et al. Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women. Human molecular genetics. 2016;25(3):620-629.
  167. Watanabe M, Ito H, Hosono S, et al. Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population. Cancer science. 2015;106(12):1738-1743.
  168. Wen W, Shu XO, Guo X, et al. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry. Breast cancer research : BCR. 2016;18(1):124.
  169. Wyszynski A, Hong CC, Lam K, et al. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human molecular genetics. 2016;25(17):3863-3876.
  170. Yabe M, Yabe H, Morimoto T, et al. The phenotype and clinical course of Japanese Fanconi Anaemia infants is influenced by patient, but not maternal ALDH2 genotype. British journal of haematology. 2016;175(3):457-461.
  171. Yamaguchi M, Uemura H, Arisawa K, et al. Association between brain-muscle-ARNT-like protein-2 (BMAL2) gene polymorphism and type 2 diabetes mellitus in obese Japanese individuals: A cross-sectional analysis of the Japan Multi-institutional Collaborative Cohort Study. Diabetes research and clinical practice. 2015;110(3):301-308.
  172. Yoshimura A, Ito H, Nishino Y, et al. Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan. Journal of epidemiology. 2018.
  173. Yoshizato T, Nannya Y, Atsuta Y, et al. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood. 2017;129(17):2347-2358.
  174. Zeng C, Guo X, Long J, et al. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast cancer research : BCR. 2016;18(1):64.
  175. Zeng C, Matsuda K, Jia WH, et al. Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk. Gastroenterology. 2016;150(7):1633-1645.

このページのトップへ